Analytical Data
-
基因名
NIP7
- Application
-
别名
KD93
-
种属
Human
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9Y221
-
表达区间
1-180aa
-
分子量
36.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
NIP7, or Nuclear Import Protein 7, is a pivotal component involved in the nuclear transport of proteins, particularly those that play critical roles in various cellular processes. Understanding the mechanisms by which NIP7 functions is essential for elucidating cellular pathways related to gene expression, cell cycle regulation, and response to stress. Research indicates that NIP7 interacts with various nuclear transport receptors to facilitate the import of proteins containing nuclear localization signals (NLS). Furthermore, alterations in NIP7 activity have been linked to several diseases, including cancers and viral infections, where the hijacking of nuclear transport mechanisms can lead to aberrant cellular functioning. The recombinant production of NIP7 has become a focal point for studies aiming to characterize its structural and functional properties, provide insights into its role in disease pathology, and explore its potential as a therapeutic target. By studying NIP7 in a controlled laboratory environment, researchers can manipulate its expression and interactions, leading to a better understanding of its involvement in nuclear import pathways. Consequently, the development of NIP7 as a recombinant protein not only enhances our understanding of nuclear transport dynamics but also opens new avenues for drug discovery and therapeutic interventions in diseases characterized by dysfunctional nuclear transport.












